North America Clinical Chemistry Analyser Market – Industry Trends and Forecast to 2030

North America Clinical Chemistry Analyser Market, By Product (Analysers, Reagents, Calibrators, Controls, Standards, Others), Analyser Technology (Semi- Automated Clinical Chemistry Analysers, Fully Automated Clinical Chemistry Analysers),  Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel), End User Analysis (Hospitals, Academic Research Centres, Diagnostic Laboratories, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2030.

North America Clinical Chemistry Analyzer Market Analysis and Size

A clinical chemistry analyzer is used to analyze blood serum, plasma, urine, and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination. The chemical analyzers can be employed in small point-of-care clinics and high-throughput clinical labs to determine the concentration of metabolites, proteins, sugars, electrolytes, and others. In this device, samples are first inserted in a slot or tray, programmed through a keypad, and results are displayed on a screen. The analyzers are available as bench top models, compact bedside models, and high-throughput floor-based units. Clinical analyzers are used to monitor diseases such as diabetes, testing for metabolic functions or cardiac markers, and drugs-of-abuse testing. Technological advancements in clinical chemistry analyzers enable users to obtain accurate results in less time.

Data Bridge Market Research analyses that the clinical chemistry analyzer market was valued at USD 6.96 billion in 2022 and is expected to reach the value of USD 10.21 billion by the year 2030, at a CAGR of 4.51% during the forecast period. This indicates the market value. “Analyser” dominates the product segment of the clinical chemistry analyzer market owing to the growing demand for point-of-care testing. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Clinical Chemistry Analyzer Market Scope and Segmentation

Market Definition

From the name itself, it is clear that a clinical chemistry analyzer is used to analyze the amount of electrolytes, proteins, and/or drugs or certain metabolites in plasma, urine, cerebrospinal fluid, serum, and other bodily fluids.          

North America Clinical Chemistry Analyzer Market Dynamics

Drivers

• Rising Prevalence of Chronic Diseases

The prevalence of chronic diseases such as diabetes, cardiovascular disorders, and kidney diseases. Clinical chemistry analyzers are extensively used in the diagnosis and monitoring of these conditions. This in turn has carved the way for the growth of the market.

• Growing Geriatric Population

The aging population is driving the demand for healthcare services, including diagnostic tests. Elderly individuals are more prone to various diseases and require regular monitoring. Clinical chemistry analyzers can assist healthcare professionals in assessing organ function, metabolic abnormalities, and medication efficacy. This demographic trend is expected to boost market growth.

• Technological Advancements

Advances in technology have led to the development of more sophisticated and automated clinical chemistry analyzers. These analyzers offer improved performance, higher throughput, and enhanced connectivity features to patients and healthcare providers, and the rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further expected to boost the market growth.  

Opportunities

The government initiatives, schemes, or funding that support and promote the innovation and development of the diagnostic market provide growth opportunities for the market players in the forecast period of 2022 to 2029. Additionally, the rising infectious disease penetration rate, increasing adoption of digital health solution, rise in personalized and precise diagnostics globally, and increasing per capita expenditure on health care is expected to further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, and high costs associated with chemical analyzers in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This clinical chemistry analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability
• In April 2022, Sysmex Europe launched its new three-part differential system, the XQ-320 XQ-Series Automated Hematology Analyzer. With reliable technology and a new level of usability, the XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments

North America Clinical Chemistry Analyser Market Scope

The clinical chemistry analyzer market is segmented on the basis of product, analyzer technology, test analysis, and end-users analysis. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Analyzers
• Reagents
• Calibrators
• Controls
• Standards
• Others

Analyser Technology

• Semi- Automated Clinical Chemistry Analysers
• Fully Automated Clinical Chemistry Analysers

Test Analysis

• Basic Metabolic Panel (BMP)
• Liver Panel
• Electrolyte Panel
• Renal Profile
• Lipid Profile
• Specialty Chemical Tests
• Thyroid Function Panel

End User Analysis

• Hospitals
• Academic Research Centres
• Diagnostic Laboratories
• Others

North America Clinical Chemistry Analyser Market Regional Analysis/Insights

The clinical chemistry analyzer market is analysed and market size insights and trends are provided by country, product, analyzer technology, test analysis, and end-users analysis as referenced above.

The countries covered in the clinical chemistry analyzer market report are U.S., Canada, and Mexico.

The U.S. is expected to dominate the clinical chemistry analyzer market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of chronic disease, and the rising number of geriatric population in this region.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The clinical chemistry analyzer market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the clinical chemistry analyzer market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the clinical chemistry analyzer market. The data is available for the historic period 2010-2020.

Competitive Landscape and Clinical chemistry analyzer Market Share Analysis

The clinical chemistry analyzer market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the clinical chemistry analyzer market.

Some of the major players operating in the clinical chemistry analyzer market are:

• F. Hoffman-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Abbott (US)
• Thermo Fisher Scientific Inc (US)
• Siemens AG (Germany)
• HORIBA Ltd (Japan)
• Sysmex Corporation (Japan)
• HITACHI (Japan)
• EKF Diagnostics Holdings plc (UK)
• Ortho Clinical Diagnostics (US)
• ELITECH Group (France)
• Mindray Medical International Limited (China)
• BIOBASE Group (China)
• SFRI Medical Diagnostics (France)
• Trivitron Healthcare Pvt, Ltd. (India)
• Randox Laboratories Ltd (UK)